Showing results (281-290 of 1,017) with videos related to
Sort By:
Pageof 102
International Angiology : a Journal of the International Union of Angiology|May 22, 2004
Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episodeE Ombandza-Moussa, M M Samama, M H Horellou, et al.Thrombosis Research. Supplement|January 1, 1988
Defective thrombolysis due to collagen incorporation in fibrin clotsM Mirshahi, J Soria, H Lu, et al.Blood|August 1, 1988
Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosisG Nguyen, M H Horellou, E K Kruithof, et al.Thrombosis and Haemostasis|July 31, 1998
Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparinP Toulon, B Boutière, M H Horellou, et al.Journal of Thrombosis and Haemostasis : JTH|April 28, 2007
Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generationG T Gerotziafas, A D Petropoulou, E Verdy, et al.Journal of Cardiovascular Pharmacology|April 26, 2013
The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitorJeanne Mendell, Frank Lee, Shuquan Chen, et al.Journal of Thrombosis and Haemostasis : JTH|October 3, 2007
Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO studyC-M Samama, P Ravaud, F Parent, et al.Acta Anaesthesiologica Scandinavica|September 16, 2010
Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference?A Godier, M Durand, D Smadja, et al.Haemostasis|January 1, 1996
Are low-molecular-weight heparins useful for the prophylaxis and treatment of arterial thrombi?C M Samama, S Combe, P Ill, et al.Thrombosis Research|July 1, 1988
The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activityJ M Walenga, L Bara, M Petitou, et al.Pageof 102